| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.51B | +18.2% |
| R&D Expense | $11.4M | +56.2% |
| SG&A Expense | $64.3M | +10.0% |
| Operating Income | $10.8M | +338.6% |
| Pre-tax Income | $20.9M | -0.7% |
| Income Tax | $44.3M | +7.4% |
| Net Income | -$23.4M | -16.0% |
| EPS (Basic) | -$0.21 | -16.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $151.7M | -29.4% |
| Accounts Receivable | $469.1M | +11.9% |
| Inventory | $143.3M | -6.8% |
| Current Assets | $851.6M | -1.6% |
| Total Assets | $2.01B | +3.9% |
| Current Liabilities | $488.9M | +11.7% |
| Long-term Debt | $20.0M | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $138.3M | +72.5% |
| Capital Expenditures | $122.1M | +49.1% |
| Investing Cash Flow | -$148.2M | -108.2% |
| Financing Cash Flow | -$49.3M | -92.6% |
| Free Cash Flow | $16.2M | +1033.7% |
| Total Liabilities |
| $717.1M |
| +10.1% |
| Stockholders' Equity | $1.30B | +0.8% |